��ɫ��˫

The goal of our work in cancer and blood disorders is, very simply, to find a cure. To do so, we’re constantly searching for new biomarkers (molecules that show whether bodily conditions are normal or cancerous) and better treatments.

Our work is organized within the ��ɫ��˫ Center for Cancer and Blood Disorders (NCCBD), a pediatric cancer center that includes our clinical and pediatric cancer research programs at the Nemours Children’s Hospital, Delaware, Nemours Children’s Hospital, Florida and Nemours Children’s Health, Jacksonville, Orlando and Pensacola, Fla. Each of our locations has been recognized for having outstanding participation in clinical trials, and for clinical trial access and management.

The ��ɫ��˫ Center for Cancer and Blood Disorders is fortunate to have excellent leadership. Our physician leaders participate or play a leadership role in a variety of national cancer organizations and studies.

Corinna Schultz (Wilmington, Del.)
Interim Division Chief of Hematology/Oncology, (Lisa Dean Moseley Foundation Institute for Cancer & Blood Disorders)

Emi Caywood (Wilmington, Del.)
NCORP PI Lead for Enterprise + COG Site PI Lead, Director of Transplant and Cellular Therapy

Robin E. Miller, MD (Wilmington, Del.)

Dr. Miller serves as Nemours Children’s Hospital, Delaware’s Cancer Control Champion for COG. She is the director of the Sickle Cell Program at the hospital and has been awarded the Delaware End-of-Life Coalition Physician Excellence Award.

Scott M. Bradfield, MD (Jacksonville, Fla.)

Dr. Bradfield is our Cancer Control Champion for Florida, and committee member of our Community Clinical Oncology Program. Dr. Bradfield is an assistant professor of Pediatrics at Mayo School of Medicine and Associate Division Chief at ��ɫ��˫, Jacksonville. He has been the Cancer Committee Chairman in Jacksonville for many years, emphasizing quality of care with improved outcomes. His main research focus is in cancer control, currently serving as the Study Principal Investigator for a Suncoast Research Base cancer study.

Cynthia A. Gauger, MD (Jacksonville, Fla.)

A nationally recognized expert in pediatric bleeding disorders, Dr. Gauger has been at ��ɫ��˫, Jacksonville since 2000. She is an Assistant Professor of Pediatrics at the University of Florida Medical School. She also serves as the Medical Director of the Hemophilia Treatment Center and is very active with the national and state Hemophilia Foundations. Dr. Gauger’s primary areas of interest are in hemostasis (a process which causes bleeding to stop), sickle cell disease thrombosis (blood clots in sickle cell patients), and benign hematology (the study of blood, blood-forming organs, and blood diseases).

Anderson Collier (Jacksonville, Fla.)
Division Chief of Hematology/Oncology (PLAYERS)

Michael J. Joyce, MD, PhD (Jacksonville, Fla.)

Dr. Joyce has been with ��ɫ��˫, Jacksonville since 1990 and has run our hematopoietic stem cell transplantation (HSCT) program since 1994. He currently serves as both the overall program director and director of the pediatric Blood and Marrow Transplantation Program of the Mayo Clinic, Nemours Children’s Clinic, and Wolfson Children’s Hospital. He’s also served as the Chair of the Institutional Review Board (IRB), which ensures that safe research protocols are followed and that participants are protected for the Baptist Health Care System since 2004. Dr. Joyce’s interests include stem cell and umbilical cord blood transplantation.

Vibhuti Agarwal (Orlando)
COG PI Site lead, NCORP PI